Leading researches say that chronic diseases can be treated with the help of nucleoside polymerase inhibitor, R1626, along with standard hepatitis C therapy.
They point out a marked increase in antiviral effect in patients who were administered ribavirin with a combination of R1626 and peginterferon alfa-2a.
Out of more than 100 patients having [...]
